Home
About
Overview
Sharing Data
ORCID
Help
History (1)
CDK4/6 inhibition in early and advanced hormone receptor-positive, HER2-negative breast cancer.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
CDK4/6 inhibition in early and advanced hormone receptor-positive, HER2-negative breast cancer.
CDK4/6 inhibition in early and advanced hormone receptor-positive, HER2-negative breast cancer. Expert Rev Anticancer Ther. 2025 Jun; 25(6):675-686.
View in:
PubMed
subject areas
Aminopyridines
Antineoplastic Combined Chemotherapy Protocols
Benzimidazoles
Breast Neoplasms
Cyclin-Dependent Kinase 4
Cyclin-Dependent Kinase 6
Female
Humans
Neoplasm Staging
Protein Kinase Inhibitors
Purines
Receptor, ErbB-2
Receptors, Estrogen
Receptors, Progesterone
authors with profiles
Rita Nanda
Sudha Yarlagadda